欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FI/H/0840/001
药品名称Triveram 10 mg/5 mg/5 mg
活性成分
    • Amlodipine besilate 6.94 mg
    • Atorvastatin calcium 10.82 mg
    • Perindopril arginine salt 5.0 mg
剂型Film-coated tablet
上市许可持有人Les Laboratoires Servier 50 rue Carnot 92284 Suresnes Cedex France
参考成员国 - 产品名称Finland (FI)
Triveram
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
    • Luxembourg (LU)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Croatia (HR)
许可日期2015/07/23
最近更新日期2024/10/04
药物ATC编码
    • C10BX11 atorvastatin, amlodipine and perindopril
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase